Pegfilgrastim: all 137 studies that test it
Page 1 of 2. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- An Open-label Prospective Study to Evaluate the Efficacy and Safety of Pegfilgrastim in Triple-Negative Breast Cancer Patients Receiving AC Regimen Following Paclitaxel and Carboplatin as Neoadjuvant TherapyRecruitingNCT07525869Not applicable
- Prevention of Sacituzumab Govitecan-related Neutropenia in Patients With Metastatic Triple Negative Breast CancerRecruitingNCT06616987Phase 2
- Compare the Efficacy and Safety of QL0605 Injections at Different TimepointsRecruitingNCT06616571Phase 4
- Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma PatientsRecruitingNCT06520176Phase 3
- The Neuroprotective Effect of PEG-GCSF in the Traumatic Optic NeuropathyRecruitingNCT06168188Early Phase 1
- Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary CancersRecruitingNCT06135896Phase 2
- Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed MedulloblastomaRecruitingNCT05535166Phase 2
- Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract CancerRecruitingNCT04628767Phase 2/3
- Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell TumoursRecruitingNCT02582697Phase 3
- Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic SyndromeRecruitingNCT01624805Phase 2
- Pharmacokinetic Comparability Study in Healthy Participants - PF-06881894 On-Body Injector Relative to Prefilled SyringeCompletedNCT05194579Phase 1Results posted
- Comparative Immunogenicity Study of Multiple Doses of Proposed Pegfilgrastim Biosimilar, INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.CompletedNCT04015232Phase 1Results posted
- Comparative, Pharmacokinetic and Pharmacodynamic Study of Subcutaneous Injections of INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.CompletedNCT04014062Phase 1Results posted
- Split-Dose R-CHOP for Older Adults With DLBCLActive, not recruitingNCT03943901Phase 2Results posted
- Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast CancerCompletedNCT03511378Phase 4Results posted
- Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast CancerTerminatedNCT03329378Phase 2Results posted
- SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and CyclophosphamideCompletedNCT02953340Phase 3Results posted
- A Study Of The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body.CompletedNCT02650193Phase 2Results posted
- SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE)CompletedNCT02643420Phase 3Results posted
- Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in Patients With Advanced Stage Ovarian CarcinomaTerminatedNCT02469116Phase 2Results posted
- Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract CancerCompletedNCT02412670Phase 2Results posted
- Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung CancerTerminatedNCT02157116Phase 2Results posted
- Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®CompletedNCT01735175Phase 3Results posted
- Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast CancerCompletedNCT01724866Phase 2Results posted
- Dacarbazine and Carmustine in Metastatic MelanomaTerminatedNCT01692691Phase 2Results posted
- Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone LymphomaCompletedNCT01682044Phase 2Results posted
- Dose Dense TC + Pegfilgrastim Support for Breast CancerCompletedNCT01671319Phase 2Results posted
- Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT01557959Phase 2Results posted
- Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-FilgrastimCompletedNCT01516736Phase 3Results posted
- Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT01266447Phase 2Results posted
- Reversing Type 1 Diabetes After it is EstablishedCompletedNCT01106157Phase 1/2Results posted
- A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT01076504Phase 2Results posted
- Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial CarcinomaCompletedNCT00808639Phase 2Results posted
- Feasibility and Cost Analysis of PBSC Mobilization Using Pegfilgrastim in Hematologic MalignanciesTerminatedNCT00689884Not applicableResults posted
- Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast CancerCompletedNCT00645333Phase 1/2Results posted
- Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast CancerCompletedNCT00615901Not applicableResults posted
- Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube CancerCompletedNCT00569673Phase 2Results posted
- G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung CancerCompletedNCT00554463Phase 2Results posted
- Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney FunctionCompletedNCT00478361Phase 2Results posted
- Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell TumorsCompletedNCT00470366Phase 2Results posted
- Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's LymphomaCompletedNCT00278161Phase 2Results posted
- Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC)CompletedNCT00240097Phase 2Results posted
- Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon CancerCompletedNCT00094809Phase 2Results posted
- NEO-adjuvant Chemo-immunotherapy in Pancreatic CancerActive, not recruitingNCT06094140Phase 2
- Efficacy of Generic Pegfilgrastim vs Brand Name Pegfilrastim for Neutrophil Recovery After AutotransplantCompletedNCT05338047Phase 2
- Evaluation and Modeling of the Effect of G-CSF on the Evolution of Polynuclear Neutrophils During Dense Dose Epirubicin-Cyclophosphamide RegenerationCompletedNCT05296317Not applicable
- Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast CancerCompletedNCT05283616Phase 3
- A Study of KRN125 in Patients With Multiple Myeloma and Malignant LymphomaCompletedNCT05007652Phase 2
- A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant ChemotherapyCompletedNCT04781959Phase 4
- Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell LymphomaActive, not recruitingNCT04759586Phase 3
- A Phase 1 Study to Assess the Immunogenicity of QL0605 Compared to US Neulasta in Healthy SubjectsStatus unknownNCT04651036Phase 1
- Plinabulin iv Solution in Prevention of TAC Induced NeutropeniaCompletedNCT04227990Phase 2
- KRN125 for Mobilization of Hematopoietic Stem CellsCompletedNCT03993639Phase 2
- Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast CancerActive, not recruitingNCT03571633Phase 2
- Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.Status unknownNCT03404752Phase 3
- Nanogen Pegcyte Clinical Study for the Prevention of CIN in Breast-cancer Patients.CompletedNCT03381417Phase 3
- Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer PatientsCompletedNCT03376503Phase 1
- A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy VolunteersCompletedNCT03273842Phase 1
- Safety and Immunogenicity of MSB11455 in Healthy ParticipantsCompletedNCT03251339Phase 1
- Pharmacokinetic/Pharmacodynamic Equivalence of MSB11455 in Healthy SubjectsCompletedNCT03251248Phase 1
- Study Comparing TPI-120 and Neulasta Administered Through Subcutaneous Route in Healthy Adult SubjectsCompletedNCT03206229Phase 1
- Comparative Immunogenicity Study Comparing TPI-120 to Neulasta® in Healthy Adult SubjectsCompletedNCT03202927Phase 1
- Study to Compare the Pharmacokinetics and Pharmacodynamics of 6 mg RGB-02 to 6 mg NeulastaCompletedNCT03146988Phase 1
- Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML PatientsStatus unknownNCT03045627Phase 2
- A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma PatientsCompletedNCT02963389Phase 1
- Immunogenicity and Pharmacodynamic of B12019 and Neulasta® in Healthy SubjectsCompletedNCT02912377Phase 1
- Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.Active, not recruitingNCT02909036Phase 1
- An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL)CompletedNCT02782845Phase 4
- Pegfilgrastim in Patients With Alcoholic HepatitisCompletedNCT02776059Phase 2
- Study to Assess the Pharmacokinetic and Pharmacodynamic Bioequivalence of CHS-1701 With NeulastaCompletedNCT02650973Phase 1
- Pharmacokinetic and Pharmacodynamics of B12019 and Neulasta® in Healthy SubjectsCompletedNCT02629562Phase 1
- A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy ParticipantsCompletedNCT02629289Phase 1
- Pharmacokinetics and Pharmacodynamics Comparison Study Between Two Pegfilgrastim FormulationsCompletedNCT02589301Phase 1
- Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)CompletedNCT02543255Phase 2
- Minimal Islet Transplant at Diabetes OnsetCompletedNCT02505893Phase 2
- Lonquek for Autologous Stem Cell MobilizationStatus unknownNCT02488382Phase 1/2
- Assessing the Immunogenicity of 2 Subcutaneous Doses of CHS-1701 (Coherus Pegfilgrastim) With 2 Subcutaneous Doses Neulasta®CompletedNCT02418104Phase 1
- Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive LymphomaTerminatedNCT02392039Early Phase 1
- Comparison of the Pharmacokinetic and Pharmacodynamic Biosimilarity of CHS-1701 (Coherus Pegfilgrastim) With Neulasta® (Pegfilgrastim)CompletedNCT02385851Phase 1
- PK, PD, Safety and Tolerability of Lipegfilgrastim in Healthy Japanese and Caucasian ParticipantsCompletedNCT02306915Phase 1
- Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive LymphomaStatus unknownNCT02238873Phase 3
- A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced NeutropeniaCompletedNCT02044276Phase 3
- Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced NeutropeniaCompletedNCT01923545Phase 2
- Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced NeutropeniaStatus unknownNCT01918241Phase 2
- High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin LymphomaActive, not recruitingNCT01840566Phase 1
- Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced NeutropeniaCompletedNCT01674855Phase 3
- Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy PatientsStatus unknownNCT01637493Phase 1
- PK/PD of XM22 in Children With Ewing Family of Tumors or RhabdomyosarcomaCompletedNCT01585649Phase 1
- Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell TransplantationTerminatedNCT01541072Not applicable
- GCPGC in Chemotherapy-induced NeutropeniaCompletedNCT01328938Phase 2/3
- Peg-Granulocyte-Colony Stimulating Factor (GCSF) for Coronary Collateral Growth in Coronary Artery Disease PatientsCompletedNCT00886509Not applicable
- Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.Status unknownNCT00777673Phase 2
- Pegfilgrastim for Stem Cell Mobilization in Children (Meg-5)Status unknownNCT00751894Phase 2
- Evaluation of Pegfilgrastim for Stem Cell Mobilization in ChildrenTerminatedNCT00695370Phase 2
- Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT00682383Phase 2
- Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin LymphomaCompletedNCT00678327Phase 3
- Neulasta in Type 1 DiabetesCompletedNCT00662519Phase 1
- Various G-CSF Regimens to Prevent Infection During ChemotherapyCompletedNCT00536081Phase 3
- High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple MyelomaStatus unknownNCT00526734Phase 2
- Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell TumorsCompletedNCT00453232Phase 2